Insight
Life Sciences Snapshot – Q3 2024 – A Quarterly Report on Financing Trends
October.07.2024
Navigating ARPA-H
Insight
Life Sciences Snapshot – Q2 2024 – A Quarterly Report on Financing Trends
June.26.2024
Novel Approaches to Treating Neurodegenerative Diseases
Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q4 2023
November.10.2023
Leveraging Alternative Financing
Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q3 2023
July.25.2023
Venture Funding and Tech Trends in AI in Drug Discovery
Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q2 2023
April.25.2023
This edition of Orrick’s life sciences publication series reviews key trends of venture investment in the life sciences industry during Q1 2023.
Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q1 2023
February.14.2023
Venture Funding and Tech Trends in Mental Health
Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q4 2022
October.24.2022
Leveraging Non-Dilutive Financing For Drug Development and Favorably Licensing Developed Products as a Global Health Model
Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q3 2022
July.27.2022
Evolving Antitrust Scrutiny of Life Sciences M&A—What's in the Pipeline?
Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q2 2022
April.26.2022
A Conversation on Leveraging Spinouts to Preserve and Create Value During Financing Rounds, M&A and IPO Planning
Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q1 2022
February.16.2022
A Conversation on the Future of Longevity, Cell Regeneration and Senescence
Insight
Best Practices in ESG: Internal Management of Public Company ESG Programs
by Ashley Walter and Hayden Goudy | February.10.2022
We studied ESG internal management practices at 19 public companies headquartered in the U.S. and identified five key ESG management best practices.
Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q4 2021
October.19.2021
VC Investment Surges in European Life Science